LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5 (Q9853)

From Wikibase.slis.ua.edu
Revision as of 15:46, 21 May 2020 by Admin (talk | contribs) (‎Created claim: Property:P105: 169-176, #quickstatements; #temporary_batch_1590074839150)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
LoConte NK, et al. Invest. N. Drugs (2015) cited as Ref 590 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    LoConte NK
    0 references
    2015
    0 references
    Invest. N. Drugs
    0 references
    33
    0 references
    A multicenter phase 1 study of gamma -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors (English)
    0 references
    169-176
    0 references